| Ident. | Authors (with country if any) | Title |
|---|
| 000085 (2017) |
Nicholas Dowdall [Royaume-Uni] ; Peter J. Cooper [Royaume-Uni, Afrique du Sud] ; Mark Tomlinson [Afrique du Sud] ; Sarah Skeen [Afrique du Sud] ; Frances Gardner [Royaume-Uni] ; Lynne Murray [Royaume-Uni, Afrique du Sud] | The Benefits of Early Book Sharing (BEBS) for child cognitive and socio-emotional development in South Africa: study protocol for a randomised controlled trial |
| 000086 (2017) |
Tamsen J. Rochat [Royaume-Uni] ; Alan Stein [Royaume-Uni] ; Mario Cortina-Borja [Royaume-Uni] ; Frank Tanser [Afrique du Sud] ; Ruth M. Bland [Royaume-Uni] | The Amagugu intervention for disclosure of maternal HIV to uninfected primary school-aged children in South Africa: a randomised controlled trial. |
| 000148 (2017) |
Pedro Cahn [Argentine] ; Richard Kaplan [Afrique du Sud] ; Paul E. Sax [États-Unis] ; Kathleen Squires [États-Unis] ; Jean-Michel Molina [France] ; Anchalee Avihingsanon [Thaïlande] ; Winai Ratanasuwan [Thaïlande] ; Evelyn Rojas [Guatemala] ; Mohammed Rassool [Afrique du Sud] ; Mark Bloch [Australie] ; Linos Vandekerckhove [Belgique] ; Peter Ruane [États-Unis] ; Yazdan Yazdanpanah [France] ; Christine Katlama [France] ; Xia Xu [États-Unis] ; Anthony Rodgers [États-Unis] ; Lilly East [États-Unis] ; Larissa Wenning [États-Unis] ; Sandy Rawlins [États-Unis] ; Brenda Homony [États-Unis] ; Peter Sklar [États-Unis] ; Bach-Yen Nguyen [États-Unis] ; Randi Leavitt [États-Unis] ; Hedy Teppler [États-Unis] | Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. |
| 000155 (2017) |
Jienchi Dorward [Afrique du Sud] ; Nigel Garrett [Afrique du Sud] ; Justice Quame-Amaglo [États-Unis] ; Natasha Samsunder [Afrique du Sud] ; Hope Ngobese [Afrique du Sud] ; Noluthando Ngomane [Afrique du Sud] ; Pravikrishnen Moodley [Afrique du Sud] ; Koleka Mlisana [Afrique du Sud] ; Torin Schaafsma [États-Unis] ; Deborah Donnell [États-Unis] ; Ruanne Barnabas [États-Unis] ; Kogieleum Naidoo [Afrique du Sud] ; Salim Abdool Karim [Afrique du Sud] ; Connie Celum [États-Unis] ; Paul K. Drain [États-Unis] | Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study. |
| 000361 (2017) |
Catherine Orrell [Afrique du Sud] ; Debbie P. Hagins [États-Unis] ; Elena Belonosova [Russie] ; Norma Porteiro [Argentine] ; Sharon Walmsley [Canada] ; Vicenç Falc [Espagne] ; Choy Y. Man [États-Unis] ; Alicia Aylott [Royaume-Uni] ; Ann M. Buchanan [États-Unis] ; Brian Wynne [États-Unis] ; Cindy Vavro [États-Unis] ; Michael Aboud [Royaume-Uni] ; Kimberly Y. Smith [États-Unis] | Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study. |
| 000390 (2017) |
Jemma O'Connor [Royaume-Uni] ; Michael J. Vjecha [États-Unis] ; Andrew N. Phillips [Royaume-Uni] ; Brian Angus [Royaume-Uni] ; David Cooper [Australie] ; Beatriz Grinsztejn [Brésil] ; Gustavo Lopardo [Argentine] ; Satyajit Das [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Aimee Wilkin [États-Unis] ; Hartwig Klinker [Allemagne] ; Pacharee Kantipong [Thaïlande] ; Karin L. Klingman [États-Unis] ; David Jilich [République tchèque] ; Elbushra Herieka [Royaume-Uni] ; Eileen Denning [États-Unis] ; Ibrahim Abubakar [Royaume-Uni] ; Fred Gordin [États-Unis] ; Jens D. Lundgren [Danemark] | Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. |
| 000426 (2017) |
Linda-Gail Bekker [Afrique du Sud] ; Surita Roux [Afrique du Sud] ; Elaine Sebastien [Afrique du Sud] ; Ntando Yola [Afrique du Sud] ; K Rivet Amico [États-Unis] ; James P. Hughes [États-Unis] ; Mark A. Marzinke [États-Unis] ; Craig W. Hendrix [États-Unis] ; Peter L. Anderson [États-Unis] ; Vanessa Elharrar [États-Unis] ; Michael Stirratt [États-Unis] ; James F. Rooney [États-Unis] ; Estelle Piwowar-Manning [États-Unis] ; Susan H. Eshleman [États-Unis] ; Laura Mckinstry [États-Unis] ; Maoji Li [États-Unis] ; Bonnie J. Dye [États-Unis] ; Robert M. Grant [États-Unis] | Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. |
| 000481 (2017) |
Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie] | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. |
| 000522 (2017) |
Richard Hayes [Royaume-Uni] ; Sian Floyd [Royaume-Uni] ; Ab Schaap [Royaume-Uni] ; Kwame Shanaube [Zambie] ; Peter Bock [Afrique du Sud] ; Kalpana Sabapathy [Royaume-Uni] ; Sam Griffith [États-Unis] ; Deborah Donnell [États-Unis] ; Estelle Piwowar-Manning [États-Unis] ; Wafaa El-Sadr [États-Unis] ; Nulda Beyers [Afrique du Sud] ; Helen Ayles [Zambie] ; Sarah Fidler [Royaume-Uni] | A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. |
| 000528 (2017) |
Munyaradzi Madhombiro [Zimbabwe] ; Bazondlile Dube-Marimbe [Zimbabwe] ; Michelle Dube [Zimbabwe] ; Dixon Chibanda [Zimbabwe] ; Moleen Zunza [Afrique du Sud] ; Simbarashe Rusakaniko [Zimbabwe] ; David Stewart [États-Unis] ; Soraya Seedat [Afrique du Sud] | A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART. |
| 000533 (2017) |
Penelope Reimers [Afrique du Sud] ; Kiersten Israel-Ballard [États-Unis] ; Marlies Craig [Afrique du Sud] ; Lenore Spies [Afrique du Sud] ; Ibou Thior [États-Unis] ; Frank Tanser [Afrique du Sud] ; Anna Coutsoudis [Afrique du Sud] | A Cluster Randomised Trial to Determine the Efficacy of the "Feeding Buddies" Programme in Improving Exclusive Breastfeeding Rates Among HIV-Infected Women in Rural KwaZulu-Natal, South Africa. |
| 000582 (2016) |
Anna Coutsoudis [Afrique du Sud] ; Brodie Daniels [Afrique du Sud] ; Eshia Moodley-Govender [Afrique du Sud] ; Noluthando Ngomane [Afrique du Sud] ; Linda Zako [Afrique du Sud] ; Elizabeth Spooner [Afrique du Sud] ; Photini Kiepiela [Afrique du Sud] ; Shabashini Reddy [Afrique du Sud] ; Louise Kuhn [États-Unis] ; Gita Ramjee [Afrique du Sud] | Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol |
| 000605 (2016) |
Ronnie P. Kasirye [Ouganda, Royaume-Uni] ; Kathy Baisley [Royaume-Uni] ; Paula Munderi [Ouganda] ; Jonathan Levin [Ouganda, Afrique du Sud] ; Zacchaeus Anywaine [Ouganda] ; Andrew Nunn [Royaume-Uni] ; Anatoli Kamali [Ouganda] ; Heiner Grosskurth [Royaume-Uni] | Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study |
| 000620 (2016) |
Catherine Mathews [Afrique du Sud] ; Sander M. Eggers [Pays-Bas] ; Loraine Townsend [Afrique du Sud] ; Leif E. Aar [Norvège] ; Petrus J. De Vries [Afrique du Sud] ; Amanda J. Mason-Jones [Afrique du Sud, Royaume-Uni] ; Petra De Koker [Afrique du Sud] ; Tracy Mcclinton Appollis [Afrique du Sud] ; Yolisa Mtshizana [Afrique du Sud] ; Joy Koech [Afrique du Sud] ; Annegreet Wubs [Norvège] ; Hein De Vries [Pays-Bas] | Effects of PREPARE, a Multi-component, School-Based HIV and Intimate Partner Violence (IPV) Prevention Programme on Adolescent Sexual Risk Behaviour and IPV: Cluster Randomised Controlled Trial |
| 000A98 (2013) |
Tanya Doherty [Afrique du Sud] ; Hanani Tabana ; Debra Jackson ; Reshma Naik ; Wanga Zembe ; Carl Lombard ; Sonja Swanevelder ; Matthew P. Fox ; Anna Thorson ; Anna Mia Ekström ; Mickey Chopra | Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial. |
| 000C33 (2012) |
Keira Lowther [Royaume-Uni] ; Victoria Simms [Royaume-Uni] ; Lucy Selman [Royaume-Uni] ; Lorraine Sherr [Royaume-Uni] ; Liz Gwyther [Afrique du Sud] ; Hellen Kariuki [Kenya] ; Aabid Ahmed [Kenya] ; Zipporah Ali [Kenya] ; Rachel Jenkins [Royaume-Uni] ; Irene J. Higginson [Royaume-Uni] ; Richard Harding [Royaume-Uni] | Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy |
| 001118 (2010) |
Sonia Lewycka [Royaume-Uni] ; Charles Mwansambo [Malawi] ; Peter Kazembe [Malawi] ; Tambosi Phiri [Malawi] ; Andrew Mganga [Malawi] ; Mikey Rosato [Royaume-Uni] ; Hilda Chapota [Malawi] ; Florida Malamba [Malawi] ; Stefania Vergnano [Royaume-Uni] ; Marie-Louise Newell [Afrique du Sud] ; David Osrin [Royaume-Uni] ; Anthony Costello [Royaume-Uni] | A cluster randomised controlled trial of the community effectiveness of two interventions in rural Malawi to improve health care and to reduce maternal, newborn and infant mortality |
| 001285 (2009) |
J. Sobngwi Ambekou [France] ; D. Taljaard [Afrique du Sud] ; M. Nieuwoudt [Afrique du Sud] ; P. Lissouba [France] ; A. Puren [Afrique du Sud] ; B. Auvert [France] | Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention |
| 001592 (2005) |
Nandi Siegfried ; Mike Clarke ; Jimmy Volmink [Afrique du Sud] | Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution |
| 001826 (1998) |
David Wilkinson [Afrique du Sud] ; S B Squire ; Paul Garner | Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials |
